TBPH Total Non-Current Liabilities
Theravance Biopharma Inc · Total Non-Current Liabilities
TBPH Total Non-Current Liabilities
Latest reported$150.55Mperiod ending
TBPH FY Total Non-Current Liabilities ($118.66M → $150.55M)
Annual total non-current liabilities
High-resolution chart · PNG
TBPH total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 150,545,000 | |
| 146,531,000 | |
| 144,237,000 | |
| 136,885,000 | |
| 654,805,000 | |
| 649,237,000 | |
| 520,963,000 | |
| 513,270,000 | |
| 263,670,000 | |
| 239,755,000 | |
| 7,581,000 | |
| 6,728,000 | |
| 5,359,000 | |
| 0 | |
| 118,664,000 |